• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

mRNA COVID-19 vaccine is well tolerated in patients with cutaneous and systemic mastocytosis with mast cell activation symptoms and anaphylaxis.

作者信息

Rama Tiago Azenha, Moreira André, Castells Mariana

机构信息

Serviço de Imunoalergologia, Centro Hospitalar Universitário São João, Porto, Portugal; Serviço de Imunologia Básica e Clínica, Departamento de Patologia, Faculdade de Medicina, Universidade do Porto, Porto, Portugal.

Serviço de Imunoalergologia, Centro Hospitalar Universitário São João, Porto, Portugal; Serviço de Imunologia Básica e Clínica, Departamento de Patologia, Faculdade de Medicina, Universidade do Porto, Porto, Portugal; EPIUnit - Instituto de Saúde Pública da Universidade do Porto, Porto, Portugal, Faculdade de Medicina da Universidade do Porto, Porto, Portugal.

出版信息

J Allergy Clin Immunol. 2021 Mar;147(3):877-878. doi: 10.1016/j.jaci.2021.01.004. Epub 2021 Jan 19.

DOI:10.1016/j.jaci.2021.01.004
PMID:33485650
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7816615/
Abstract
摘要

相似文献

1
mRNA COVID-19 vaccine is well tolerated in patients with cutaneous and systemic mastocytosis with mast cell activation symptoms and anaphylaxis.mRNA新冠疫苗在患有皮肤和全身性肥大细胞增多症且伴有肥大细胞活化症状和过敏反应的患者中耐受性良好。
J Allergy Clin Immunol. 2021 Mar;147(3):877-878. doi: 10.1016/j.jaci.2021.01.004. Epub 2021 Jan 19.
2
Delving Into COVID-19 Vaccination-Induced Anaphylaxis: Are mRNA Vaccines Safe in Mast Cell Disorders?深入研究新冠疫苗接种引起的过敏反应：mRNA疫苗在肥大细胞疾病中是否安全？
J Investig Allergol Clin Immunol. 2021 Apr 20;31(2):193-195. doi: 10.18176/jiaci.0680. Epub 2021 Feb 12.
3
Potential mechanisms of anaphylaxis to COVID-19 mRNA vaccines.对 COVID-19 mRNA 疫苗过敏反应的潜在机制。
J Allergy Clin Immunol. 2021 Jun;147(6):2075-2082.e2. doi: 10.1016/j.jaci.2021.04.002. Epub 2021 Apr 20.
4
Neutralizing SARS-CoV-2.中和 SARS-CoV-2
Elife. 2020 Dec 15;9:e64496. doi: 10.7554/eLife.64496.
5
[Not Available].[无可用内容]。
Rev Med Suisse. 2020 Oct 7;16(709):1895.
6
Vaccine-induced protection in aging adults and pandemic response.疫苗诱导的老年成年人保护作用与大流行应对措施
Biochem Biophys Res Commun. 2021 Jan 29;538:218-220. doi: 10.1016/j.bbrc.2020.10.090. Epub 2020 Nov 17.
7
Could mixing COVID vaccines boost immune response?混合接种新冠疫苗能增强免疫反应吗？
Nature. 2021 Feb;590(7846):375-376. doi: 10.1038/d41586-021-00315-5.
8
Antibody Titers Before and After a Third Dose of the SARS-CoV-2 BNT162b2 Vaccine in Adults Aged ≥60 Years.≥60 岁成年人接种第三剂 SARS-CoV-2 BNT162b2 疫苗前后的抗体滴度。
JAMA. 2021 Dec 7;326(21):2203-2204. doi: 10.1001/jama.2021.19885.
9
Insights from American College of Allergy, Asthma, and Immunology COVID-19 Vaccine Task Force: Allergic Reactions to mRNA SARS-CoV-2 Vaccines.美国过敏、哮喘与免疫学会2019冠状病毒病疫苗特别工作组见解：对mRNA新型冠状病毒疫苗的过敏反应
Ann Allergy Asthma Immunol. 2021 Apr;126(4):319-320. doi: 10.1016/j.anai.2021.01.017. Epub 2021 Jan 23.
10
Why Oxford's positive COVID vaccine results are puzzling scientists.为何牛津大学新冠疫苗的阳性结果令科学家们感到困惑。
Nature. 2020 Dec;588(7836):16-18. doi: 10.1038/d41586-020-03326-w.

引用本文的文献

1
Challenges in Drug and Hymenoptera Venom Hypersensitivity Diagnosis and Management in Mastocytosis.肥大细胞增多症中药物和膜翅目毒液超敏反应诊断与管理的挑战
Diagnostics (Basel). 2024 Jan 5;14(2):123. doi: 10.3390/diagnostics14020123.
2
The conundrum of COVID-19 mRNA vaccine-induced anaphylaxis.新型冠状病毒肺炎信使核糖核酸疫苗诱导的过敏反应难题。
J Allergy Clin Immunol Glob. 2023 Feb;2(1):1-13. doi: 10.1016/j.jacig.2022.10.003. Epub 2022 Dec 13.
3
Treatment of Advanced Systemic Mastocytosis with Midostaurin: Practical Guidance for Optimal Therapy and Management.米哚妥林治疗晚期系统性肥大细胞增多症：最佳治疗与管理的实用指南
Mediterr J Hematol Infect Dis. 2022 Nov 1;14(1):e2022073. doi: 10.4084/MJHID.2022.073. eCollection 2022.
4
COVID-19 Vaccination Is Safe among Mast Cell Disorder Patients, under Adequate Premedication.在充分的术前用药情况下，新冠病毒疫苗接种对肥大细胞疾病患者是安全的。
Vaccines (Basel). 2022 May 4;10(5):718. doi: 10.3390/vaccines10050718.
5
COVID-19 Vaccination Safety and Tolerability in Patients Allegedly at High Risk for Immediate Hypersensitivity Reactions.疑似有速发型超敏反应高风险患者的新冠病毒疫苗接种安全性与耐受性
Vaccines (Basel). 2022 Feb 14;10(2):286. doi: 10.3390/vaccines10020286.
6
A naturally hypersensitive porcine model may help understand the mechanism of COVID-19 mRNA vaccine-induced rare (pseudo) allergic reactions: complement activation as a possible contributing factor.一种天然超敏的猪模型可能有助于理解 COVID-19 mRNA 疫苗引起的罕见（类）过敏反应的机制：补体激活可能是一个促成因素。
Geroscience. 2022 Apr;44(2):597-618. doi: 10.1007/s11357-021-00495-y. Epub 2022 Feb 11.
7
Safety of COVID-19 vaccination in patients with clonal mast cell disorders.克隆性肥大细胞疾病患者接种新型冠状病毒肺炎疫苗的安全性
J Allergy Clin Immunol Pract. 2022 May;10(5):1374-1376.e3. doi: 10.1016/j.jaip.2022.01.030. Epub 2022 Feb 1.
8
Evaluation of the Autoimmunity and Preexisting Risky Conditions for Hypersensitivity Reactions to COVID-19 Vaccines.评估 COVID-19 疫苗过敏反应的自身免疫和潜在风险状况。
Int Arch Allergy Immunol. 2022;183(6):651-661. doi: 10.1159/000521709. Epub 2022 Feb 3.
9
[Anaphylaxis and COVID-19 vaccines].[过敏反应与新冠疫苗]
Rev Fr Allergol (2009). 2021 Dec;61(8):8S30-8S35. doi: 10.1016/S1877-0320(21)00439-5. Epub 2021 Dec 30.
10
Challenges to Vaccination against SARS-CoV-2 in Patients with Immune-Mediated Diseases.免疫介导疾病患者接种新型冠状病毒疫苗面临的挑战
Vaccines (Basel). 2021 Oct 8;9(10):1147. doi: 10.3390/vaccines9101147.